We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
-5.34%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.27B
AUM Growth
-$1.89B
Cap. Flow
-$1.48B
Cap. Flow %
-45.31%
Top 10 Hldgs %
36.77%
Holding
111
New
16
Increased
19
Reduced
19
Closed
24

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$98.2M
2
V icon
Visa
V
+$94.7M
3
LVS icon
Las Vegas Sands
LVS
+$94.4M
4
SCHW
Charles Schwab
SCHW
+$86.5M
5
SPGI icon
S&P Global
SPGI
+$84.2M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$222M
2
AMZN icon
Amazon
AMZN
+$194M
3
ADI icon
Analog Devices
ADI
+$144M
4
PWR icon
Quanta Services
PWR
+$133M
5
COR icon
Cencora
COR
+$122M

Sector Composition

Rank Sector Weight
1 Healthcare 47.04%
2 Consumer Discretionary 18.58%
3 Financials 10.68%
4 Industrials 10.44%
5 Technology 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLT icon
26
Hilton Worldwide
HLT
$71.5B
$55M 1.68%
362,703
-236,319
-39% -$34.8M
MAR icon
27
Marriott International
MAR
$92.3B
$54.3M 1.66%
309,240
-184,400
-37% -$30.7M
XLE icon
28
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$53M 1.62%
+1,385,736
New +$48M
BBWI icon
29
Bath & Body Works
BBWI
$4.1B
$49.6M 1.52%
+1,038,630
New +$56M
MQ icon
30
Marqeta
MQ
$1.66B
$44.7M 1.37%
1,012,488
+645,646
+176% +$30M
MRTX
31
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$42M 1.28%
510,331
+107,542
+27% +$11M
DECK icon
32
Deckers Outdoor
DECK
$13.3B
$39M 1.19%
854,862
-442,518
-34% -$22M
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$2.55B
$38.1M 1.16%
525,100
+39,858
+8% +$2.77M
EYPT icon
34
EyePoint Inc
EYPT
$1.2B
$35.3M 1.08%
2,909,407
+389,707
+15% +$4.27M
AGIO icon
35
Agios Pharmaceuticals
AGIO
$1.93B
$34.3M 1.05%
1,177,374
– –
INSM icon
36
Insmed
INSM
$28.6B
$31M 0.95%
1,318,432
+236,900
+22% +$5.5M
STRO icon
37
Sutro Biopharma
STRO
$421M
$30.7M 0.94%
373,240
+129,460
+53% +$12.3M
MCK icon
38
McKesson
MCK
$101B
$30M 0.92%
+97,980
New +$26.6M
WYNN icon
39
Wynn Resorts
WYNN
$10.6B
$29.2M 0.89%
+366,060
New +$30.8M
MRNS
40
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$25.9M 0.79%
2,766,000
+127,225
+5% +$1.26M
KALV
41
DELISTED
KalVista Pharmaceuticals
KALV
$25.7M 0.79%
1,746,300
– –
PNT
42
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$24M 0.73%
3,014,408
+341,545
+13% +$2.17M
NTRA icon
43
Natera
NTRA
$46.4B
$23.8M 0.73%
584,660
-51,500
-8% -$3.09M
KDNY
44
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$23.5M 0.72%
1,434,200
+186,732
+15% +$2.54M
KZR
45
DELISTED
Kezar Life Sciences
KZR
$23.4M 0.72%
140,996
– –
CANO
46
DELISTED
Cano Health, Inc.
CANO
$23.3M 0.71%
36,685
-62,045
-63% -$39.1M
XOP icon
47
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.51B
$22.2M 0.68%
+164,970
New +$19M
ACLX
48
DELISTED
Arcellx
ACLX
$21.5M 0.66%
+1,533,059
New +$25.6M
XENE icon
49
Xenon Pharmaceuticals
XENE
$6.12B
$21.2M 0.65%
692,000
– –
HRTX icon
50
Heron Therapeutics
HRTX
$92.9M
$16.4M 0.5%
2,869,048
+382,708
+15% +$2.8M
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Suvretta Capital Management held 111 positions worth $3.27B, down 37% from $5.16B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Suvretta Capital Management withdrew a net $1.48B in Q1 2022, closing 24 positions and reducing 19 holdings. Its most notable exit was Adobe, an estimated $222M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Suvretta Capital Management opened a new position in Centene worth $101M.

  • Suvretta Capital Management's largest Q1 2022 buy was Centene: 1,197,206 shares worth $101M.
  • Suvretta Capital Management added most to Marqeta in Q1 2022, an estimated $30M increase.
  • Suvretta Capital Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $194M.
  • Suvretta Capital Management fully exited Adobe in Q1 2022, selling an estimated $222M.
  • Suvretta Capital Management's ten largest holdings make up 37% of its $3.27B portfolio in Q1 2022.
  • Suvretta Capital Management opened 16 new positions and closed 24 in Q1 2022.
  • Suvretta Capital Management's portfolio value fell 37% quarter-over-quarter to $3.27B.

Based on Suvretta Capital Management's 13F filing for Q1 2022, filed 16 May 2022.